

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 3.92129982 |
| 2 | apoptotic cell clearance (GO:0043277) | 3.84015170 |
| 3 | trophectodermal cell differentiation (GO:0001829) | 3.77951493 |
| 4 | regulation of hippo signaling (GO:0035330) | 3.75743916 |
| 5 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.64166790 |
| 6 | epithelial cell-cell adhesion (GO:0090136) | 3.52193387 |
| 7 | heterochromatin organization (GO:0070828) | 3.49054686 |
| 8 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.47823153 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 3.42967267 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 3.38193151 |
| 11 | COPI coating of Golgi vesicle (GO:0048205) | 3.38193151 |
| 12 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.36330339 |
| 13 | regulation of extracellular matrix disassembly (GO:0010715) | 3.28526763 |
| 14 | maternal placenta development (GO:0001893) | 3.28316572 |
| 15 | pinocytosis (GO:0006907) | 3.27196916 |
| 16 | hepatocyte apoptotic process (GO:0097284) | 3.26487939 |
| 17 | endodermal cell differentiation (GO:0035987) | 3.11634850 |
| 18 | hypotonic response (GO:0006971) | 3.10270806 |
| 19 | pentose-phosphate shunt (GO:0006098) | 3.08805527 |
| 20 | embryonic process involved in female pregnancy (GO:0060136) | 3.05048106 |
| 21 | regulation of cholesterol homeostasis (GO:2000188) | 3.03312896 |
| 22 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.01817352 |
| 23 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.01598981 |
| 24 | positive regulation of histone deacetylation (GO:0031065) | 2.99728930 |
| 25 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.96909661 |
| 26 | positive regulation of extracellular matrix organization (GO:1903055) | 2.95707488 |
| 27 | cell-substrate junction assembly (GO:0007044) | 2.94134024 |
| 28 | apoptotic process involved in morphogenesis (GO:0060561) | 2.93977371 |
| 29 | mannose metabolic process (GO:0006013) | 2.93940981 |
| 30 | adherens junction assembly (GO:0034333) | 2.93800807 |
| 31 | wound healing, spreading of epidermal cells (GO:0035313) | 2.92515476 |
| 32 | negative regulation of cell size (GO:0045792) | 2.91680079 |
| 33 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.88814801 |
| 34 | regulation of tight junction assembly (GO:2000810) | 2.87343712 |
| 35 | establishment of endothelial barrier (GO:0061028) | 2.85030009 |
| 36 | polarized epithelial cell differentiation (GO:0030859) | 2.84614734 |
| 37 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.83047061 |
| 38 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.82550773 |
| 39 | basement membrane organization (GO:0071711) | 2.79989024 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.79379272 |
| 41 | regulation of cholesterol storage (GO:0010885) | 2.77645662 |
| 42 | activation of Rac GTPase activity (GO:0032863) | 2.75887152 |
| 43 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.74785939 |
| 44 | NADPH regeneration (GO:0006740) | 2.74475374 |
| 45 | skin morphogenesis (GO:0043589) | 2.73180909 |
| 46 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.69262824 |
| 47 | regulation of integrin activation (GO:0033623) | 2.67888111 |
| 48 | hippo signaling (GO:0035329) | 2.67087865 |
| 49 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.66926648 |
| 50 | regulation of early endosome to late endosome transport (GO:2000641) | 2.66748636 |
| 51 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.66073012 |
| 52 | response to laminar fluid shear stress (GO:0034616) | 2.65097986 |
| 53 | intestinal epithelial cell development (GO:0060576) | 2.64865617 |
| 54 | hormone catabolic process (GO:0042447) | 2.63801123 |
| 55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.63730830 |
| 56 | modulation by symbiont of host immune response (GO:0052553) | 2.63730830 |
| 57 | positive regulation by symbiont of host defense response (GO:0052509) | 2.63730830 |
| 58 | modulation by symbiont of host defense response (GO:0052031) | 2.63730830 |
| 59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.63730830 |
| 60 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.63730830 |
| 61 | positive regulation of receptor recycling (GO:0001921) | 2.62753998 |
| 62 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62151537 |
| 63 | negative regulation of fatty acid transport (GO:2000192) | 2.62090640 |
| 64 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.62048465 |
| 65 | NLS-bearing protein import into nucleus (GO:0006607) | 2.61695386 |
| 66 | glucose 6-phosphate metabolic process (GO:0051156) | 2.58367390 |
| 67 | hemidesmosome assembly (GO:0031581) | 2.57080701 |
| 68 | protein retention in ER lumen (GO:0006621) | 2.57072362 |
| 69 | positive regulation of nuclease activity (GO:0032075) | 2.55647026 |
| 70 | cortical actin cytoskeleton organization (GO:0030866) | 2.55454803 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.54566464 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.54566464 |
| 73 | epoxygenase P450 pathway (GO:0019373) | 2.53999672 |
| 74 | actin filament depolymerization (GO:0030042) | 2.53508180 |
| 75 | intestinal absorption (GO:0050892) | 2.52273848 |
| 76 | regulation of extracellular matrix organization (GO:1903053) | 2.50958177 |
| 77 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.50896531 |
| 78 | stress fiber assembly (GO:0043149) | 2.50261062 |
| 79 | positive regulation of p38MAPK cascade (GO:1900745) | 2.50008725 |
| 80 | establishment of apical/basal cell polarity (GO:0035089) | 2.49518650 |
| 81 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.49385760 |
| 82 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.48283362 |
| 83 | mRNA stabilization (GO:0048255) | 2.47860046 |
| 84 | RNA stabilization (GO:0043489) | 2.47860046 |
| 85 | platelet aggregation (GO:0070527) | 2.47816361 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.45937245 |
| 87 | membrane raft organization (GO:0031579) | 2.45867104 |
| 88 | cell-substrate adherens junction assembly (GO:0007045) | 2.45723539 |
| 89 | focal adhesion assembly (GO:0048041) | 2.45723539 |
| 90 | membrane protein ectodomain proteolysis (GO:0006509) | 2.45577116 |
| 91 | vagina development (GO:0060068) | 2.45489548 |
| 92 | regulation of gene silencing by RNA (GO:0060966) | 2.44837620 |
| 93 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.44837620 |
| 94 | regulation of gene silencing by miRNA (GO:0060964) | 2.44837620 |
| 95 | morphogenesis of an endothelium (GO:0003159) | 2.44690494 |
| 96 | endothelial tube morphogenesis (GO:0061154) | 2.44690494 |
| 97 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.44145636 |
| 98 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.43230139 |
| 99 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.42742048 |
| 100 | vitamin A metabolic process (GO:0006776) | 2.42450774 |
| 101 | sulfur amino acid catabolic process (GO:0000098) | 2.42405486 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.41974665 |
| 103 | response to peptidoglycan (GO:0032494) | 2.41847646 |
| 104 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.41832365 |
| 105 | actin filament bundle assembly (GO:0051017) | 2.40912215 |
| 106 | actin filament bundle organization (GO:0061572) | 2.40912215 |
| 107 | vesicle coating (GO:0006901) | 2.40337190 |
| 108 | positive regulation of protein deacetylation (GO:0090312) | 2.39397937 |
| 109 | labyrinthine layer blood vessel development (GO:0060716) | 2.38955895 |
| 110 | regulation of leukocyte degranulation (GO:0043300) | 2.38788808 |
| 111 | female genitalia development (GO:0030540) | 2.38679409 |
| 112 | negative regulation of cell killing (GO:0031342) | 2.37800582 |
| 113 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.37800582 |
| 114 | embryonic placenta development (GO:0001892) | 2.36438855 |
| 115 | regulation of nuclease activity (GO:0032069) | 2.34305154 |
| 116 | regulation of protein heterodimerization activity (GO:0043497) | 2.33994680 |
| 117 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.31607358 |
| 118 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.29644136 |
| 119 | substrate-dependent cell migration (GO:0006929) | 2.28846574 |
| 120 | desmosome organization (GO:0002934) | 2.28731471 |
| 121 | intestinal cholesterol absorption (GO:0030299) | 2.28283437 |
| 122 | modulation by symbiont of host cellular process (GO:0044068) | 2.27527897 |
| 123 | wound healing, spreading of cells (GO:0044319) | 2.26762927 |
| 124 | blood vessel endothelial cell migration (GO:0043534) | 2.26662178 |
| 125 | interferon-gamma secretion (GO:0072643) | 2.26188406 |
| 126 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.25184647 |
| 127 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.24228272 |
| 128 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.24203673 |
| 129 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.23498369 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.23430709 |
| 131 | cortical cytoskeleton organization (GO:0030865) | 2.22788212 |
| 132 | regulation of podosome assembly (GO:0071801) | 2.22757806 |
| 133 | glycosphingolipid catabolic process (GO:0046479) | 2.22486967 |
| 134 | semaphorin-plexin signaling pathway (GO:0071526) | 2.22079808 |
| 135 | detection of other organism (GO:0098543) | 2.21587873 |
| 136 | regulation of translational fidelity (GO:0006450) | 2.21064337 |
| 137 | peptide catabolic process (GO:0043171) | 2.19662086 |
| 138 | protein localization to endosome (GO:0036010) | 2.19621961 |
| 139 | protein localization to kinetochore (GO:0034501) | 2.19109623 |
| 140 | glucose catabolic process (GO:0006007) | 2.18909244 |
| 141 | hyaluronan catabolic process (GO:0030214) | 2.18610751 |
| 142 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.18583035 |
| 143 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.18536557 |
| 144 | cellular response to unfolded protein (GO:0034620) | 2.18138399 |
| 145 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.18052451 |
| 146 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.17997288 |
| 147 | regulation of defense response to virus by virus (GO:0050690) | 2.17696576 |
| 148 | cellular response to vitamin (GO:0071295) | 2.17541693 |
| 149 | mammary gland epithelial cell proliferation (GO:0033598) | 2.17119931 |
| 150 | barbed-end actin filament capping (GO:0051016) | 2.16924229 |
| 151 | endocytic recycling (GO:0032456) | 2.16639002 |
| 152 | negative regulation of anoikis (GO:2000811) | 2.15955744 |
| 153 | regulation of superoxide anion generation (GO:0032928) | 2.15575754 |
| 154 | negative regulation of viral release from host cell (GO:1902187) | 2.15135540 |
| 155 | COPII vesicle coating (GO:0048208) | 2.15133490 |
| 156 | adhesion of symbiont to host (GO:0044406) | 2.14558249 |
| 157 | virion attachment to host cell (GO:0019062) | 2.14337423 |
| 158 | adhesion of symbiont to host cell (GO:0044650) | 2.14337423 |
| 159 | collagen fibril organization (GO:0030199) | 2.13808554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.36169369 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.31830491 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.20447359 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.37325944 |
| 5 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.20673818 |
| 6 | * MYC_22102868_ChIP-Seq_BL_Human | 2.19850921 |
| 7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.17637520 |
| 8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.17637520 |
| 9 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.17637520 |
| 10 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.12465060 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12412868 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05054467 |
| 13 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.01029669 |
| 14 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.99418379 |
| 15 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.98781619 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96574645 |
| 17 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81569002 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.80409202 |
| 19 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.79538538 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.78776852 |
| 21 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78302485 |
| 22 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76463362 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75183977 |
| 24 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.74941584 |
| 25 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.74521492 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.72405061 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.68821981 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.67371583 |
| 29 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.67128546 |
| 30 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66695170 |
| 31 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.65543341 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65145687 |
| 33 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.64098479 |
| 34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.63706571 |
| 35 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.61979471 |
| 36 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.61400276 |
| 37 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.60890369 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60788489 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59455993 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59256125 |
| 41 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.58875322 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58346987 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56487373 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54108395 |
| 45 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.53570672 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52778854 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.50714090 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.48711148 |
| 49 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48661823 |
| 50 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.48455201 |
| 51 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45239091 |
| 52 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43174139 |
| 53 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.41043613 |
| 54 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.40019924 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38408864 |
| 56 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37822820 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35994307 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35230479 |
| 59 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31631790 |
| 60 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.31454751 |
| 61 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31012968 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29730134 |
| 63 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29171742 |
| 64 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28340442 |
| 65 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27968307 |
| 66 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.26286035 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25677178 |
| 68 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24276267 |
| 69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23447118 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23237567 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21823420 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21574187 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21278093 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20714269 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20279110 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20277416 |
| 77 | * MAF_26560356_Chip-Seq_TH1_Human | 1.19761458 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19689528 |
| 79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19151081 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18729967 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17621246 |
| 82 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15612847 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15003189 |
| 84 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13974697 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13891548 |
| 86 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.13803001 |
| 87 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13337271 |
| 88 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13333573 |
| 89 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13059460 |
| 90 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12995670 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12372426 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10953284 |
| 93 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.10792479 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10610519 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09819663 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.09562340 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09017144 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08255164 |
| 99 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07652229 |
| 100 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.07463404 |
| 101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06764550 |
| 102 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06548682 |
| 103 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06540966 |
| 104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06179165 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05759908 |
| 106 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.05597502 |
| 107 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05554736 |
| 108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05554736 |
| 109 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05527546 |
| 110 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04698836 |
| 111 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.03873589 |
| 112 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.03866382 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03825324 |
| 114 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03799003 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03779163 |
| 116 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03494675 |
| 117 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03469292 |
| 118 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03058663 |
| 119 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02582523 |
| 120 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02457254 |
| 121 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02156152 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01637477 |
| 123 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01159025 |
| 124 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01013740 |
| 125 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.00515629 |
| 126 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00430850 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00224304 |
| 128 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.99681261 |
| 129 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99371001 |
| 130 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99081223 |
| 131 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98983003 |
| 132 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98106380 |
| 133 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97761373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.75239626 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 3.37978649 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 3.11151150 |
| 4 | MP0003566_abnormal_cell_adhesion | 2.80942118 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.61504634 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.42125457 |
| 7 | MP0005451_abnormal_body_composition | 2.35785198 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.30103653 |
| 9 | MP0005076_abnormal_cell_differentiation | 2.24081805 |
| 10 | MP0005023_abnormal_wound_healing | 2.17830672 |
| 11 | MP0002254_reproductive_system_inflammat | 1.99639734 |
| 12 | MP0009840_abnormal_foam_cell | 1.92015604 |
| 13 | MP0003303_peritoneal_inflammation | 1.83835110 |
| 14 | MP0004272_abnormal_basement_membrane | 1.77519422 |
| 15 | MP0001849_ear_inflammation | 1.69575741 |
| 16 | MP0005257_abnormal_intraocular_pressure | 1.67969402 |
| 17 | MP0005360_urolithiasis | 1.67662599 |
| 18 | MP0008260_abnormal_autophagy | 1.66402334 |
| 19 | MP0005409_darkened_coat_color | 1.65930857 |
| 20 | MP0003091_abnormal_cell_migration | 1.65148878 |
| 21 | MP0006054_spinal_hemorrhage | 1.64988468 |
| 22 | MP0003283_abnormal_digestive_organ | 1.61443200 |
| 23 | MP0005275_abnormal_skin_tensile | 1.53414128 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.51895942 |
| 25 | MP0003436_decreased_susceptibility_to | 1.49927528 |
| 26 | MP0000858_altered_metastatic_potential | 1.47179156 |
| 27 | MP0004858_abnormal_nervous_system | 1.44544798 |
| 28 | MP0009278_abnormal_bone_marrow | 1.42839558 |
| 29 | MP0003279_aneurysm | 1.41944092 |
| 30 | MP0002998_abnormal_bone_remodeling | 1.41605289 |
| 31 | MP0005623_abnormal_meninges_morphology | 1.38414343 |
| 32 | MP0003453_abnormal_keratinocyte_physiol | 1.35611937 |
| 33 | MP0002419_abnormal_innate_immunity | 1.31972446 |
| 34 | MP0004947_skin_inflammation | 1.29802928 |
| 35 | MP0009053_abnormal_anal_canal | 1.29554588 |
| 36 | MP0003828_pulmonary_edema | 1.25409097 |
| 37 | MP0003448_altered_tumor_morphology | 1.25094791 |
| 38 | MP0002086_abnormal_extraembryonic_tissu | 1.22915547 |
| 39 | MP0000537_abnormal_urethra_morphology | 1.22240476 |
| 40 | MP0001958_emphysema | 1.18680622 |
| 41 | MP0003724_increased_susceptibility_to | 1.17047895 |
| 42 | MP0000490_abnormal_crypts_of | 1.15348001 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.14944569 |
| 44 | MP0010030_abnormal_orbit_morphology | 1.14719850 |
| 45 | MP0003329_amyloid_beta_deposits | 1.14557927 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.13883920 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.11861832 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.11593250 |
| 49 | MP0010307_abnormal_tumor_latency | 1.11558475 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.10883252 |
| 51 | MP0005164_abnormal_response_to | 1.10226105 |
| 52 | MP0003252_abnormal_bile_duct | 1.09613267 |
| 53 | MP0001348_abnormal_lacrimal_gland | 1.08962327 |
| 54 | MP0000477_abnormal_intestine_morphology | 1.08625196 |
| 55 | MP0006082_CNS_inflammation | 1.08352472 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.07580223 |
| 57 | MP0005025_abnormal_response_to | 1.05667089 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.03738062 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.03332966 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.03069043 |
| 61 | MP0004197_abnormal_fetal_growth/weight/ | 1.02783515 |
| 62 | MP0001666_abnormal_nutrient_absorption | 1.02318842 |
| 63 | MP0000604_amyloidosis | 1.01492773 |
| 64 | MP0002088_abnormal_embryonic_growth/wei | 1.01278660 |
| 65 | MP0001542_abnormal_bone_strength | 1.01115644 |
| 66 | MP0000733_abnormal_muscle_development | 1.00810975 |
| 67 | MP0003984_embryonic_growth_retardation | 1.00342084 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 0.97107640 |
| 69 | MP0004883_abnormal_blood_vessel | 0.95754115 |
| 70 | MP0010329_abnormal_lipoprotein_level | 0.95617924 |
| 71 | MP0000609_abnormal_liver_physiology | 0.95328404 |
| 72 | MP0005380_embryogenesis_phenotype | 0.95062334 |
| 73 | MP0001672_abnormal_embryogenesis/_devel | 0.95062334 |
| 74 | MP0003075_altered_response_to | 0.94048578 |
| 75 | MP0001533_abnormal_skeleton_physiology | 0.92937972 |
| 76 | MP0001730_embryonic_growth_arrest | 0.92102015 |
| 77 | MP0002060_abnormal_skin_morphology | 0.91052393 |
| 78 | MP0005503_abnormal_tendon_morphology | 0.90743787 |
| 79 | MP0003045_fibrosis | 0.90082107 |
| 80 | MP0001790_abnormal_immune_system | 0.87624555 |
| 81 | MP0005387_immune_system_phenotype | 0.87624555 |
| 82 | MP0003795_abnormal_bone_structure | 0.87226504 |
| 83 | MP0005000_abnormal_immune_tolerance | 0.87035192 |
| 84 | MP0002796_impaired_skin_barrier | 0.87020819 |
| 85 | MP0003119_abnormal_digestive_system | 0.86781810 |
| 86 | MP0000350_abnormal_cell_proliferation | 0.86638174 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.86574592 |
| 88 | MP0002925_abnormal_cardiovascular_devel | 0.86421066 |
| 89 | MP0005621_abnormal_cell_physiology | 0.85832934 |
| 90 | MP0002933_joint_inflammation | 0.85705365 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.85357370 |
| 92 | MP0004233_abnormal_muscle_weight | 0.85248681 |
| 93 | MP0008004_abnormal_stomach_pH | 0.83974946 |
| 94 | MP0004510_myositis | 0.83436262 |
| 95 | MP0009785_altered_susceptibility_to | 0.81122510 |
| 96 | MP0005248_abnormal_Harderian_gland | 0.81018576 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.80887598 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.80879911 |
| 99 | MP0004957_abnormal_blastocyst_morpholog | 0.80616248 |
| 100 | MP0000249_abnormal_blood_vessel | 0.80351510 |
| 101 | MP0001915_intracranial_hemorrhage | 0.80182082 |
| 102 | MP0001243_abnormal_dermal_layer | 0.80170885 |
| 103 | MP0002084_abnormal_developmental_patter | 0.79632866 |
| 104 | MP0005367_renal/urinary_system_phenotyp | 0.78804778 |
| 105 | MP0000516_abnormal_urinary_system | 0.78804778 |
| 106 | MP0000685_abnormal_immune_system | 0.78541595 |
| 107 | MP0002452_abnormal_antigen_presenting | 0.78506658 |
| 108 | MP0000343_altered_response_to | 0.77804825 |
| 109 | MP0002139_abnormal_hepatobiliary_system | 0.77531109 |
| 110 | MP0000598_abnormal_liver_morphology | 0.77190949 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.76319668 |
| 112 | MP0005165_increased_susceptibility_to | 0.75963585 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.75432411 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.74988764 |
| 115 | MP0005390_skeleton_phenotype | 0.73921144 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.73901482 |
| 117 | MP0002405_respiratory_system_inflammati | 0.73418290 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.72347021 |
| 119 | MP0001819_abnormal_immune_cell | 0.72277357 |
| 120 | MP0000428_abnormal_craniofacial_morphol | 0.72109000 |
| 121 | MP0001614_abnormal_blood_vessel | 0.71640900 |
| 122 | MP0005508_abnormal_skeleton_morphology | 0.71633465 |
| 123 | MP0002420_abnormal_adaptive_immunity | 0.71426654 |
| 124 | MP0001697_abnormal_embryo_size | 0.71396738 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.70479154 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.69976028 |
| 127 | MP0001545_abnormal_hematopoietic_system | 0.69976028 |
| 128 | MP0005501_abnormal_skin_physiology | 0.69736273 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.69436115 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.69374096 |
| 131 | MP0002092_abnormal_eye_morphology | 0.69274376 |
| 132 | MP0005166_decreased_susceptibility_to | 0.69148865 |
| 133 | MP0001851_eye_inflammation | 0.69083458 |
| 134 | MP0009333_abnormal_splenocyte_physiolog | 0.68905877 |
| 135 | MP0005365_abnormal_bile_salt | 0.68354717 |
| 136 | MP0001216_abnormal_epidermal_layer | 0.68097470 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.67918599 |
| 138 | MP0001873_stomach_inflammation | 0.67668143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.05287089 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.49957112 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.32667614 |
| 4 | Peritonitis (HP:0002586) | 3.07016074 |
| 5 | Vascular tortuosity (HP:0004948) | 3.06486522 |
| 6 | Arterial tortuosity (HP:0005116) | 3.04770612 |
| 7 | Cervical subluxation (HP:0003308) | 3.02547471 |
| 8 | Hand muscle atrophy (HP:0009130) | 2.95574543 |
| 9 | Shallow orbits (HP:0000586) | 2.91132305 |
| 10 | Ankle contracture (HP:0006466) | 2.80255126 |
| 11 | Distal upper limb amyotrophy (HP:0007149) | 2.78946636 |
| 12 | Upper limb amyotrophy (HP:0009129) | 2.78946636 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 2.71813561 |
| 14 | Distal lower limb amyotrophy (HP:0008944) | 2.66075910 |
| 15 | Micronodular cirrhosis (HP:0001413) | 2.60600261 |
| 16 | Mitral valve prolapse (HP:0001634) | 2.59649110 |
| 17 | Atrophic scars (HP:0001075) | 2.59154260 |
| 18 | Eczematoid dermatitis (HP:0000976) | 2.58115829 |
| 19 | Esophageal varix (HP:0002040) | 2.57849449 |
| 20 | Broad face (HP:0000283) | 2.52589441 |
| 21 | Increased connective tissue (HP:0009025) | 2.52090787 |
| 22 | Flat acetabular roof (HP:0003180) | 2.49631076 |
| 23 | Genu recurvatum (HP:0002816) | 2.49283652 |
| 24 | Spondylolisthesis (HP:0003302) | 2.48989251 |
| 25 | Dilatation of the ascending aorta (HP:0005111) | 2.41875426 |
| 26 | Wormian bones (HP:0002645) | 2.39834809 |
| 27 | Ulnar bowing (HP:0003031) | 2.36644536 |
| 28 | Spinal rigidity (HP:0003306) | 2.36003679 |
| 29 | Radial bowing (HP:0002986) | 2.34816780 |
| 30 | Disproportionate tall stature (HP:0001519) | 2.34706006 |
| 31 | Aneurysm (HP:0002617) | 2.33509961 |
| 32 | Aortic aneurysm (HP:0004942) | 2.31814542 |
| 33 | Hemorrhage of the eye (HP:0011885) | 2.31275745 |
| 34 | Aortic dissection (HP:0002647) | 2.29269295 |
| 35 | Short nail (HP:0001799) | 2.22686906 |
| 36 | Thin bony cortex (HP:0002753) | 2.22084159 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.21879631 |
| 38 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.20354657 |
| 39 | Multiple enchondromatosis (HP:0005701) | 2.19508231 |
| 40 | Abnormal cartilage morphology (HP:0002763) | 2.11806963 |
| 41 | Mitral regurgitation (HP:0001653) | 2.11438032 |
| 42 | Short humerus (HP:0005792) | 2.11113334 |
| 43 | Lymphangioma (HP:0100764) | 2.07321823 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.05003623 |
| 45 | Increased mean platelet volume (HP:0011877) | 2.04806211 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.04082886 |
| 47 | Hyperacusis (HP:0010780) | 2.02574515 |
| 48 | Cellulitis (HP:0100658) | 2.01991316 |
| 49 | Bowing of the arm (HP:0006488) | 2.01802435 |
| 50 | Bowed forearm bones (HP:0003956) | 2.01802435 |
| 51 | Selective tooth agenesis (HP:0001592) | 2.01594119 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01186449 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.01186449 |
| 54 | Fused cervical vertebrae (HP:0002949) | 1.99570543 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 1.99358765 |
| 56 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.99322833 |
| 57 | Myocardial infarction (HP:0001658) | 1.99312322 |
| 58 | Increased cerebral lipofuscin (HP:0011813) | 1.98297511 |
| 59 | Blue sclerae (HP:0000592) | 1.98238913 |
| 60 | Abnormal ossification of hand bones (HP:0005921) | 1.97790019 |
| 61 | Pseudobulbar signs (HP:0002200) | 1.96253701 |
| 62 | Gastrointestinal dysmotility (HP:0002579) | 1.95537543 |
| 63 | Ependymoma (HP:0002888) | 1.95241108 |
| 64 | Fragile skin (HP:0001030) | 1.94387984 |
| 65 | Joint laxity (HP:0001388) | 1.94258902 |
| 66 | Abnormality of carpal bone ossification (HP:0006257) | 1.93675770 |
| 67 | Bladder diverticulum (HP:0000015) | 1.93577333 |
| 68 | Mitral stenosis (HP:0001718) | 1.93085021 |
| 69 | Increased variability in muscle fiber diameter (HP:0003557) | 1.92496436 |
| 70 | Abnormality of dentin (HP:0010299) | 1.91663573 |
| 71 | Achilles tendon contracture (HP:0001771) | 1.91490802 |
| 72 | Subacute progressive viral hepatitis (HP:0006572) | 1.90948903 |
| 73 | Trismus (HP:0000211) | 1.90599533 |
| 74 | Abnormal platelet volume (HP:0011876) | 1.90546491 |
| 75 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.89603570 |
| 76 | Vertebral hypoplasia (HP:0008417) | 1.89603570 |
| 77 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88953251 |
| 78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88953251 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88953251 |
| 80 | Neonatal short-limb short stature (HP:0008921) | 1.88949152 |
| 81 | Abdominal distention (HP:0003270) | 1.88505233 |
| 82 | Biconcave vertebral bodies (HP:0004586) | 1.88434260 |
| 83 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.87826414 |
| 84 | Abnormality of the acetabulum (HP:0003170) | 1.86610240 |
| 85 | Syringomyelia (HP:0003396) | 1.85520472 |
| 86 | Spinal cord lesions (HP:0100561) | 1.85520472 |
| 87 | Abnormality of the Achilles tendon (HP:0005109) | 1.85355895 |
| 88 | Soft skin (HP:0000977) | 1.85180041 |
| 89 | Renal duplication (HP:0000075) | 1.83679528 |
| 90 | Increased density of long bones (HP:0006392) | 1.82963435 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82912482 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82912482 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82912482 |
| 94 | Coxa vara (HP:0002812) | 1.82429026 |
| 95 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80709224 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79335009 |
| 97 | Hyperextensible skin (HP:0000974) | 1.78094328 |
| 98 | Lower limb amyotrophy (HP:0007210) | 1.77906358 |
| 99 | Hepatoblastoma (HP:0002884) | 1.75937050 |
| 100 | Gingivitis (HP:0000230) | 1.75289806 |
| 101 | Dysostosis multiplex (HP:0000943) | 1.74841830 |
| 102 | Long palpebral fissure (HP:0000637) | 1.74637044 |
| 103 | Spastic diplegia (HP:0001264) | 1.74609492 |
| 104 | Cupped ribs (HP:0000887) | 1.73597537 |
| 105 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.72978146 |
| 106 | Vertebral compression fractures (HP:0002953) | 1.72902538 |
| 107 | Skin nodule (HP:0200036) | 1.72612966 |
| 108 | Elbow flexion contracture (HP:0002987) | 1.72147839 |
| 109 | Xanthomatosis (HP:0000991) | 1.71401174 |
| 110 | Gastrointestinal carcinoma (HP:0002672) | 1.71075023 |
| 111 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.71075023 |
| 112 | Broad metatarsal (HP:0001783) | 1.70994286 |
| 113 | Amyloidosis (HP:0011034) | 1.70043870 |
| 114 | Deep venous thrombosis (HP:0002625) | 1.69914276 |
| 115 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.69903789 |
| 116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69830636 |
| 117 | Osteolytic defects of the hand bones (HP:0009699) | 1.69830636 |
| 118 | Abnormality of the peritoneum (HP:0002585) | 1.69793779 |
| 119 | Polycythemia (HP:0001901) | 1.69657180 |
| 120 | Bone pain (HP:0002653) | 1.69001374 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.68854668 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.68854668 |
| 123 | Abnormality of the astrocytes (HP:0100707) | 1.68397864 |
| 124 | Astrocytoma (HP:0009592) | 1.68397864 |
| 125 | Back pain (HP:0003418) | 1.68383416 |
| 126 | Recurrent abscess formation (HP:0002722) | 1.67676849 |
| 127 | Slender build (HP:0001533) | 1.66431956 |
| 128 | Focal segmental glomerulosclerosis (HP:0000097) | 1.66127429 |
| 129 | Abnormality of oral frenula (HP:0000190) | 1.65920720 |
| 130 | Hallux valgus (HP:0001822) | 1.65517678 |
| 131 | Nonimmune hydrops fetalis (HP:0001790) | 1.65420631 |
| 132 | Hematochezia (HP:0002573) | 1.65160039 |
| 133 | Vertebral clefting (HP:0008428) | 1.65039430 |
| 134 | Deviation of the hallux (HP:0010051) | 1.64853138 |
| 135 | Missing ribs (HP:0000921) | 1.64695344 |
| 136 | Emphysema (HP:0002097) | 1.64430701 |
| 137 | Camptodactyly of toe (HP:0001836) | 1.64309572 |
| 138 | Menorrhagia (HP:0000132) | 1.64288625 |
| 139 | Abnormality of the nasal mucosa (HP:0000433) | 1.64160458 |
| 140 | Joint stiffness (HP:0001387) | 1.63767919 |
| 141 | Malnutrition (HP:0004395) | 1.63736032 |
| 142 | Asymmetry of the thorax (HP:0001555) | 1.62986759 |
| 143 | Spinal cord compression (HP:0002176) | 1.62719329 |
| 144 | Axonal loss (HP:0003447) | 1.62188419 |
| 145 | Bowel diverticulosis (HP:0005222) | 1.62091865 |
| 146 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.61600458 |
| 147 | Systemic lupus erythematosus (HP:0002725) | 1.60859069 |
| 148 | Abnormality of complement system (HP:0005339) | 1.59867187 |
| 149 | Striae distensae (HP:0001065) | 1.59449419 |
| 150 | Hypertriglyceridemia (HP:0002155) | 1.59397036 |
| 151 | Difficulty climbing stairs (HP:0003551) | 1.58613816 |
| 152 | Metaphyseal cupping (HP:0003021) | 1.58520055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.18265376 |
| 2 | ERN1 | 4.15928409 |
| 3 | CDK12 | 3.74055132 |
| 4 | EPHA2 | 3.40446570 |
| 5 | PKN2 | 3.04106174 |
| 6 | PRPF4B | 2.77663467 |
| 7 | RIPK1 | 2.60634322 |
| 8 | SMG1 | 2.48139518 |
| 9 | STK10 | 2.31167822 |
| 10 | IRAK3 | 2.20728330 |
| 11 | PTK6 | 2.16791719 |
| 12 | PAK4 | 2.12904107 |
| 13 | GRK6 | 1.97011027 |
| 14 | MAP3K10 | 1.96195754 |
| 15 | TTN | 1.93995236 |
| 16 | EEF2K | 1.87567740 |
| 17 | PTK2 | 1.87336949 |
| 18 | PDGFRA | 1.85086695 |
| 19 | LRRK2 | 1.65984758 |
| 20 | TGFBR2 | 1.60728034 |
| 21 | DDR2 | 1.57102679 |
| 22 | TESK1 | 1.56343575 |
| 23 | SIK1 | 1.46009230 |
| 24 | BMX | 1.44764803 |
| 25 | RPS6KB2 | 1.41537499 |
| 26 | SCYL2 | 1.40654015 |
| 27 | TESK2 | 1.34199343 |
| 28 | CDC42BPA | 1.32463204 |
| 29 | RIPK4 | 1.31364554 |
| 30 | LATS1 | 1.24836657 |
| 31 | LATS2 | 1.24477992 |
| 32 | MAP3K13 | 1.21579445 |
| 33 | PRKD2 | 1.19032066 |
| 34 | EPHB1 | 1.16228645 |
| 35 | FGFR4 | 1.15595990 |
| 36 | CSK | 1.15207339 |
| 37 | TAOK1 | 1.14236761 |
| 38 | ALK | 1.08891896 |
| 39 | KDR | 1.08285397 |
| 40 | MTOR | 1.07163144 |
| 41 | NEK9 | 1.05782154 |
| 42 | PAK2 | 1.05334487 |
| 43 | MAP2K2 | 1.05215440 |
| 44 | IRAK4 | 1.03729339 |
| 45 | MAP3K14 | 1.02860262 |
| 46 | TYRO3 | 1.02077187 |
| 47 | MATK | 1.00688311 |
| 48 | MAP3K8 | 0.99975629 |
| 49 | EPHB2 | 0.99710588 |
| 50 | MYLK | 0.99528862 |
| 51 | TBK1 | 0.99248150 |
| 52 | CSF1R | 0.97510063 |
| 53 | MAP3K6 | 0.94074939 |
| 54 | STK38 | 0.93131623 |
| 55 | NEK1 | 0.88540914 |
| 56 | FRK | 0.87456316 |
| 57 | CDK6 | 0.86449960 |
| 58 | FER | 0.86130503 |
| 59 | MAP3K3 | 0.84672286 |
| 60 | MAP3K11 | 0.84541998 |
| 61 | MST4 | 0.82739522 |
| 62 | MARK2 | 0.82138005 |
| 63 | RPS6KA2 | 0.81974464 |
| 64 | RPS6KA4 | 0.81755984 |
| 65 | MAPKAPK3 | 0.81098608 |
| 66 | ICK | 0.81007353 |
| 67 | PDPK1 | 0.80937999 |
| 68 | MAP2K3 | 0.77062304 |
| 69 | SIK3 | 0.76751214 |
| 70 | MET | 0.76427119 |
| 71 | FLT3 | 0.74634409 |
| 72 | CAMK1D | 0.74281083 |
| 73 | KSR2 | 0.73775194 |
| 74 | DYRK1B | 0.71701736 |
| 75 | TAOK3 | 0.71472540 |
| 76 | BLK | 0.65372991 |
| 77 | MAP3K9 | 0.65343942 |
| 78 | TYK2 | 0.65294043 |
| 79 | FGFR3 | 0.64964003 |
| 80 | ZAP70 | 0.64358546 |
| 81 | NEK2 | 0.64173299 |
| 82 | MST1R | 0.63937897 |
| 83 | ERBB4 | 0.62595695 |
| 84 | FGR | 0.61028838 |
| 85 | MOS | 0.60931605 |
| 86 | MAP2K1 | 0.59716550 |
| 87 | MAP4K1 | 0.59528276 |
| 88 | LIMK1 | 0.59047912 |
| 89 | PDGFRB | 0.57550004 |
| 90 | ARAF | 0.57398980 |
| 91 | JAK3 | 0.57022195 |
| 92 | PRKCI | 0.56796454 |
| 93 | TGFBR1 | 0.56320338 |
| 94 | NME2 | 0.53586571 |
| 95 | ERBB2 | 0.51145712 |
| 96 | MAPK11 | 0.50087221 |
| 97 | STK3 | 0.50083442 |
| 98 | PAK3 | 0.50062345 |
| 99 | CDK4 | 0.49953462 |
| 100 | HIPK2 | 0.49885921 |
| 101 | FGFR1 | 0.49689802 |
| 102 | RPS6KC1 | 0.49004194 |
| 103 | RPS6KL1 | 0.49004194 |
| 104 | EGFR | 0.48390233 |
| 105 | MAP3K2 | 0.48347947 |
| 106 | PIM2 | 0.47669329 |
| 107 | CHUK | 0.46832272 |
| 108 | PLK4 | 0.46577389 |
| 109 | PAK1 | 0.45873869 |
| 110 | TTK | 0.45761431 |
| 111 | JAK1 | 0.45687350 |
| 112 | ITK | 0.45466868 |
| 113 | HCK | 0.45046606 |
| 114 | RET | 0.44380588 |
| 115 | MELK | 0.43994699 |
| 116 | ROCK2 | 0.42951765 |
| 117 | LMTK2 | 0.41241613 |
| 118 | PDK1 | 0.41097433 |
| 119 | EPHA3 | 0.40883437 |
| 120 | DMPK | 0.40756147 |
| 121 | AKT2 | 0.39914546 |
| 122 | YES1 | 0.39392441 |
| 123 | MAP3K1 | 0.38934864 |
| 124 | CAMKK1 | 0.38917330 |
| 125 | TRPM7 | 0.38915272 |
| 126 | JAK2 | 0.38507623 |
| 127 | TAOK2 | 0.38427471 |
| 128 | KSR1 | 0.38143856 |
| 129 | IRAK2 | 0.37433482 |
| 130 | GSK3A | 0.37180094 |
| 131 | MAP3K7 | 0.37029423 |
| 132 | NTRK1 | 0.36269902 |
| 133 | MAPKAPK2 | 0.35406242 |
| 134 | * SRC | 0.34818061 |
| 135 | SIK2 | 0.34439902 |
| 136 | SGK3 | 0.33835141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.12539578 |
| 2 | Bladder cancer_Homo sapiens_hsa05219 | 1.83972674 |
| 3 | Adherens junction_Homo sapiens_hsa04520 | 1.81060834 |
| 4 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.71439309 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68556711 |
| 6 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.60499920 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57960216 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 1.56112898 |
| 9 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.49565908 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 1.47052603 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45004614 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43362555 |
| 13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.41110714 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.41049046 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30991028 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30898391 |
| 17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.29164813 |
| 18 | Amoebiasis_Homo sapiens_hsa05146 | 1.28903472 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.28591677 |
| 20 | Thyroid cancer_Homo sapiens_hsa05216 | 1.26985673 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26859130 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.26546034 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25881169 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22859250 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18958217 |
| 26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.17214048 |
| 27 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.17054406 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16925393 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16319458 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.15872973 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15230954 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.14354137 |
| 33 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13584424 |
| 34 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.12863919 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10753233 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09916550 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.08572495 |
| 38 | Endometrial cancer_Homo sapiens_hsa05213 | 1.06180021 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.05898004 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.05160708 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05131078 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02208620 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01705822 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00693345 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 0.99889339 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98323048 |
| 47 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.97964429 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97876462 |
| 49 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97180008 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96202997 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94990564 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.94506200 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.94262816 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.94066780 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.92479938 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92389166 |
| 57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.92112042 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91448493 |
| 59 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.91024750 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87810135 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.87376884 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86727257 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86427915 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85578472 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84734324 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.84534498 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82884024 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82832486 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.82359513 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81882642 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.81340245 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80280463 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.80015760 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79657165 |
| 75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79163511 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78230715 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77926252 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76378684 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75433411 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75165986 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74925498 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74304159 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.74274938 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73832991 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.73064175 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73013457 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72917360 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.72038263 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71631190 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70772858 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69796096 |
| 92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68825143 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67709028 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67304135 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67294341 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.67238600 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67162726 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.65949276 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65687690 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65290532 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.65050862 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.64628723 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64559872 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64168033 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62789484 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62159861 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.61623930 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61384684 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61215374 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61149531 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60761660 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.59464067 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59287802 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.58608265 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58465175 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57665342 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57029398 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55809163 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55162928 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55159448 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.53650759 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53146835 |
| 123 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52013448 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51901244 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48049056 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47816900 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47237459 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45144282 |

